GoodRx Holdings, Inc. (GDRX) Operating cash flow 2018–2025
GoodRx Holdings, Inc. (GDRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$167.9MFY2025 · since FY2018: $45.3M → $167.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $167.9M | -8.7% |
| FY2024 | $183.9M | +33.0% |
| FY2023 | $138.3M | -5.8% |
| FY2022 | $146.8M | -17.9% |
| FY2021 | $178.8M | +36.1% |
| FY2020 | $131.3M | +57.7% |
| FY2019 | $83.3M | +84.0% |
| FY2018 | $45.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GDRX financial trends
GDRX RevenueGDRX Net incomeGDRX Net marginGDRX Gross profitGDRX Gross marginGDRX Operating incomeGDRX Operating marginGDRX Free cash flowGDRX Capital expendituresGDRX Return on equityGDRX Stock buybacksGDRX Dividends paidGDRX Total assetsGDRX Total liabilitiesGDRX Shareholders’ equityGDRX overview →